Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 721 AL 735

Inhibitory concentration of propofol in combination with dexmedetomidine during microelectrode recording for deep brain stimulator insertion surgeries under general anesthesia

Lin YS, Liu KD, Chang C, Yang HZ, Tsou MY, Chu YC.

J Chin Med Assoc. 2020 Feb;83(2):188-193. doi: 10.1097/JCMA.0000000000000248.

Obstructive Sleep Apnea in Neurodegenerative Disorders: Current Evidence in Support of Benefit from Sleep Apnea Treatment

Lajoie AC, Lafontaine AL, Kimoff RJ, Kaminska M.

J Clin Med. 2020 Jan 21;9(2):297. doi: 10.3390/jcm9020297.

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease

Kelly R, Joers V, Tansey MG, McKernan DP, Dowd E.

Molecules. 2020 Jan 21;25(3):453. doi: 10.3390/molecules25030453.

The effect of fornix deep brain stimulation in brain diseases

Liu H, Temel Y, Boonstra J, Hescham S.

Cell Mol Life Sci. 2020 Sep;77(17):3279-3291. doi: 10.1007/s00018-020-03456-4. Epub 2020 Jan 23.

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease

Schneider SA, Alcalay RN.

J Neurol. 2020 Mar;267(3):860-869. doi: 10.1007/s00415-020-09705-7. Epub 2020 Jan 23.

Mirror neurons and their relationship with neurodegenerative disorders

Farina E, Borgnis F, Pozzo T.

J Neurosci Res. 2020 Jun;98(6):1070-1094. doi: 10.1002/jnr.24579. Epub 2020 Jan 23.

The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms

Guo H, Liu M, Zhang L, Wang L, Hou W, Ma Y, Ma Y.

Curr Neuropharmacol. 2020;18(6):485-500. doi: 10.2174/1570159X18666200123165652.

Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis

Gao J, Teng J, Liu Z, Cai M, Xie A.

Neurosci Lett. 2020 Feb 16;720:134778. doi: 10.1016/j.neulet.2020.134778. Epub 2020 Jan 21.

Immunotherapy for Parkinson's disease

Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL.

Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21.

LRRK2 in Parkinson disease: challenges of clinical trials

Tolosa E, Vila M, Klein C, Rascol O.

Nat Rev Neurol. 2020 Feb;16(2):97-107. doi: 10.1038/s41582-019-0301-2. Epub 2020 Jan 24.

Amyloid protein aggregates: new clients for mitochondrial energy production in the brain?

Sivanesan S, Chang E, Howell MD, Rajadas J.

FEBS J. 2020 Aug;287(16):3386-3395. doi: 10.1111/febs.15225. Epub 2020 Feb 13.

The benefits and mechanisms of exercise training for Parkinson's disease

Feng YS, Yang SD, Tan ZX, Wang MM, Xing Y, Dong F, Zhang F.

Life Sci. 2020 Mar 15;245:117345. doi: 10.1016/j.lfs.2020.117345. Epub 2020 Jan 22.

Tai Chi for improving balance and reducing falls: An overview of 14 systematic reviews

Zhong D, Xiao Q, Xiao X, Li Y, Ye J, Xia L, Zhang C, Li J, Zheng H, Jin R.

Ann Phys Rehabil Med. 2020 Nov;63(6):505-517. doi: 10.1016/j.rehab.2019.12.008. Epub 2020 Jan 22.

Mitochondrial localization of NCXs: Balancing calcium and energy homeostasis

Magi S, Piccirillo S, Preziuso A, Amoroso S, Lariccia V.

Cell Calcium. 2020 Mar;86:102162. doi: 10.1016/j.ceca.2020.102162. Epub 2020 Jan 14.

The PINK1-Parkin axis: An Overview

Tanaka K.

Neurosci Res. 2020 Oct;159:9-15. doi: 10.1016/j.neures.2020.01.006. Epub 2020 Jan 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias